Literature DB >> 26474783

Are Episodic and Chronic Migraine One Disease or Two?

Reuben Burshtein1, Aaron Burshtein2, Joshua Burshtein3, Noah Rosen4.   

Abstract

Migraine is a debilitating headache disorder that has a significant impact on the world population, in both economic and sociologic capacities. Migraine has two main categories: (1) chronic migraine (CM), defined as the patient having 15 or more headache days per month, with at least five attacks fulfilling measures for EM with aura or EM without aura, and (2) episodic migraine (EM), defined as less than 15 headache days per month. With this definition, CM can only exist in the presence of EM, and it questions whether the two are separate diseases. Migraine has a significant impact on the population, as each year, about 2.5 % of patients with EM develop new-onset CM (Manack et al., Curr Pain Headache Rep 15:70-78, 2011) (Loder et al. Headache 55:214-228, 2015), with certain risk factors being evident only with CM. In addition, there are comorbid diseases that are only associated with CM, suggesting two separate diseases rather than one. Differentiation in response to treatments, both preventive and abortive, demonstrates both a similarity and a difference in EM versus CM. Also, comparing the two processes based upon functional imaging has been a recent development, beginning to show a physiological difference in regional cortical thickness, cortical surface area, and regional volumes in patients with EM and CM. Evidence regarding whether EM and CM demonstrate one disease with a significant level of complication or if two independent processes is inconclusive, and additional research must be performed to further characterize their relationship.

Entities:  

Keywords:  Chronic migraine; Classification; Comorbidity; Epidemiology; Episodic; Migraine; Treatment

Mesh:

Year:  2015        PMID: 26474783     DOI: 10.1007/s11916-015-0529-5

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  22 in total

1.  OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Authors:  S K Aurora; D W Dodick; C C Turkel; R E DeGryse; S D Silberstein; R B Lipton; H C Diener; M F Brin
Journal:  Cephalalgia       Date:  2010-03-17       Impact factor: 6.292

Review 2.  Contributions of epidemiology to our understanding of migraine.

Authors:  Kathleen R Merikangas
Journal:  Headache       Date:  2013-02       Impact factor: 5.887

3.  An association between migraine and cutaneous allodynia.

Authors:  R Burstein; D Yarnitsky; I Goor-Aryeh; B J Ransil; Z H Bajwa
Journal:  Ann Neurol       Date:  2000-05       Impact factor: 10.422

Review 4.  Risk factors of chronic daily headache or chronic migraine.

Authors:  Soo-Jin Cho; Min Kyung Chu
Journal:  Curr Pain Headache Rep       Date:  2015-01

5.  Accurate Classification of Chronic Migraine via Brain Magnetic Resonance Imaging.

Authors:  Todd J Schwedt; Catherine D Chong; Teresa Wu; Nathan Gaw; Yinlin Fu; Jing Li
Journal:  Headache       Date:  2015-06       Impact factor: 5.887

Review 6.  Chronic migraine: epidemiology and disease burden.

Authors:  Aubrey N Manack; Dawn C Buse; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2011-02

Review 7.  Obesity, migraine, and chronic migraine: possible mechanisms of interaction.

Authors:  Marcelo E Bigal; Richard B Lipton; Philip R Holland; Peter J Goadsby
Journal:  Neurology       Date:  2007-05-22       Impact factor: 9.910

8.  Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine.

Authors:  Marcelo E Bigal; Alan M Rapoport; Richard B Lipton; Stewart J Tepper; Fred D Sheftell
Journal:  Headache       Date:  2003-04       Impact factor: 5.887

Review 9.  Chronic migraine.

Authors:  Todd J Schwedt
Journal:  BMJ       Date:  2014-03-24

10.  Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers.

Authors:  D C Buse; A Manack; D Serrano; C Turkel; R B Lipton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-02-17       Impact factor: 10.154

View more
  2 in total

1.  Volume expansion of periaqueductal gray in episodic migraine: a pilot MRI structural imaging study.

Authors:  Zhiye Chen; Xiaoyan Chen; Mengqi Liu; Shuangfeng Liu; Lin Ma; Shengyuan Yu
Journal:  J Headache Pain       Date:  2017-08-15       Impact factor: 7.277

2.  Saliva molecular inflammatory profiling in female migraine patients responsive to adjunctive cervical non-invasive vagus nerve stimulation: the MOXY Study.

Authors:  Azize Boström; Dirk Scheele; Birgit Stoffel-Wagner; Frigga Hönig; Shafqat R Chaudhry; Sajjad Muhammad; Rene Hurlemann; Joachim K Krauss; Ilana S Lendvai; Krishnan V Chakravarthy; Thomas M Kinfe
Journal:  J Transl Med       Date:  2019-02-22       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.